Levetiracetam
Levetiracetam is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Levetiracetam; Generic name: LEVETIRACETAM; Manufacturer: Mylan Pharmaceuticals Inc..
| Brand name | Levetiracetam |
|---|---|
| Generic name | LEVETIRACETAM |
| Manufacturer | Mylan Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) Levetiracetam is indicated for adjunctive therapy for the treatment of: • Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy ( 1.2 ) • Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam is indicated as adjunctive therapy for the t |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Use the oral solution for pediatric patients with body weight ≤ 20 kg ( 2.1 ) • For pediatric patients, use weight-based dosing for the oral solution with a calibrated measuring device (not a household teaspoon or tablespoon) ( 2.1 ) Partial-Onset Seizures (monotherapy or adjunctive therapy) • 1 Month to < 6 Months: 7 mg/kg twice daily; increase by 7 mg/kg twice daily every 2 weeks to recommended dose of 21 mg/kg twice daily ( 2.2 ) • 6 Months to < 4 Years: 10 mg/kg |
| Active ingredient(s) | LEVETIRACETAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a987d59-560f-4650-96ec-31aec81953b5 |